alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, October 15, 2020.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, October 15, 2020

The Court of Appeals hereby passes the following order

A21I0053. LU ANNE ESPOSITO v. KATHY SCOTT.

Upon consideration of the Application for Interlocutory Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

17102611
No. 11-7751.

#### Alejandro Flores, Petitioner v. United States.

565 U.S. 1169, 132 S. Ct. 1120,

181 L. Ed. 2d 1000,

2012 U.S. LEXIS 635.

January 17, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
# C_2018252EN.01034201.xml

| 18.7.2018 | EN | Official Journal of the European Union | C 252/342 |
| --- | --- | --- | --- |

18.7.2018

EN

Official Journal of the European Union

C 252/342

---

P8_TA(2017)0024

Subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures *

European Parliament legislative resolution of 14 February 2017 on the draft Council implementing decision on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures (12356/2016 — C8-0405/2016 — 2016/0262(NLE))

(Consultation)

(2018/C 252/36)

The European Parliament,

The European Parliament

| — | having regard to the Council draft (12356/2016), |
| --- | --- |

—

having regard to the Council draft (12356/2016),

| — | having regard to Article 39(1) of the Treaty on European Union, as amended by the Treaty of Amsterdam, and Article 9 of Protocol No 36 on transitional provisions, pursuant to which the Council consulted Parliament (C8-0405/2016), |
| --- | --- |

—

having regard to Article 39(1) of the Treaty on European Union, as amended by the Treaty of Amsterdam, and Article 9 of Protocol No 36 on transitional provisions, pursuant to which the Council consulted Parliament (C8-0405/2016),

| — | having regard to Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (1), and in particular Article 8(3) thereof, |
| --- | --- |

—

having regard to Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (1), and in particular Article 8(3) thereof,

1

| — | having regard to Rule 78c of its Rules of Procedure, |
| --- | --- |

—

having regard to Rule 78c of its Rules of Procedure,

| — | having regard to the report of the Committee on Civil Liberties, Justice and Home Affairs (A8-0024/2017), |
| --- | --- |

—

having regard to the report of the Committee on Civil Liberties, Justice and Home Affairs (A8-0024/2017),

| 1. | Approves the Council draft; |
| --- | --- |

1.

Approves the Council draft;

| 2. | Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament; |
| --- | --- |

2.

Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament;

| 3. | Asks the Council to consult Parliament again if it intends to substantially amend the text approved by Parliament; |
| --- | --- |

3.

Asks the Council to consult Parliament again if it intends to substantially amend the text approved by Parliament;

| 4. | Instructs its President to forward its position to the Council and the Commission. |
| --- | --- |

4.

Instructs its President to forward its position to the Council and the Commission.

---

(1)  OJ L 127, 20.5.2005, p. 32.

1

---
No. 11-7486.

#### Donald Leroy Davis, Petitioner v. Georgia.

565 U.S. 1180, 132 S. Ct. 1147,

181 L. Ed. 2d 1021,

2012 U.S. LEXIS 1046.

January 23, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.

Same case below, 427 Fed. Appx. 14.
**CERTIFICATIONS***
Exhibit 31.2                    
I, Glen W. Fausset, certify that:
1.      I have reviewed this quarterly report on Form 10-Q of First NationalBancshares, Inc.; 2.      Based on my knowledge, this quarterly report does not contain any untruestatement of a material fact or omit to state a material fact necessary tomake the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered bythis quarterly report; 3.      Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in allmaterial respects the financial condition, results of operations and cashflows of the registrant as of, and for, the periods presented in thisquarterly report; 4.      The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and wehave:
a) Designed such disclosure controls and procedures to ensure thatmaterial information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this quarterly reportis being prepared; b) Evaluated the effectiveness of the registrant’s disclosure controlsand procedures as of a date within 90 days prior to the filing date ofthis quarterly report (the “Evaluation Date”); and c) Presented in this quarterly report our conclusions about theeffectiveness of the disclosure controls and procedures based on ourevaluation as of the Evaluation Date;
5.      The registrant’s other certifying officers and I have disclosed, based onour most recent evaluation, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent function):
a) All significant deficiencies in the design or operation of internalcontrols which could adversely affect the registrant’s ability torecord, process, summarize and report financial data and have identifiedfor the registrant’s auditors any material weaknesses in internalcontrols; and b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internalcontrols; and
6. The registrant’s other certifying officers and I have indicated in thisquarterly report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internalcontrols subsequent to the date of our most recent evaluation, includingany corrective actions with regard to significant deficiencies andmaterial weaknesses.   Date: May 10, 2004 /s/ *Glen W. Fausset* Title: Chief Financial Officer
No. 11-7732.

#### Bobby Richardson, Petitioner v. United States.

565 U.S. 1168, 132 S. Ct. 1118,

181 L. Ed. 2d 998,

2012 U.S. LEXIS 692.

January 17, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 442 Fed. Appx. 37.
No. 11-7314.

#### Lindsey Pearson, Petitioner v. Blaine Lafler, Warden.

565 U.S. 1128, 132 S. Ct. 1039,

181 L. Ed. 2d 764,

2012 U.S. LEXIS 271.

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
No. 11-6768.

#### Henry M. Mitchell, Jr., aka Henry Cephus Hayes, Petitioner v. California.

565 U.S. 1095, 132 S. Ct. 848,

181 L. Ed. 2d 554,

2011 U.S. LEXIS 8874.

December 12, 2011.

Petition for writ of certiorari to the Supreme Court of California denied.
No. 11-6838.

#### Steven L. Pinder, Petitioner v. Ray Hobbs, Director, Arkansas Department of Correction.

565 U.S. 1152132 S. Ct. 1085,

181 L. Ed. 2d 803,

2012 U.S. LEXIS 413.

January 9, 2012.

Petition for rehearing denied.

Former decision, 565 U.S. 1069, 132 S. Ct. 782, 181 L. Ed. 2d 501, 2011 U.S. LEXIS 8585.
No. 09-8037.

#### Caswell Fenton, Petitioner v. Walter A. McNeil, Secretary, Florida Department of Corrections.

559 U.S. 948, 130 S. Ct. 1528,

176 L. Ed. 2d 128,

2010 U.S. LEXIS 1136.

February 22, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Robert Scott Rankin, 

Individually, Rachelle Rankin, 

Individually and as Next 

Friend for Avery Rankin, Kara 

s

Fourth Court of Appeals

San Antonio, Texas

December 9, 2014

No. 04-14-00494-CV

UNITED PARCEL SERVICE, INC. and Roland Leal,

Appellants

v.

Robert Scott RANKIN, Individually, Rachelle Rankin, Individually and as Next Friend for 

Avery Rankin, Kara Rankin, and Samuel Rankin, Minors,

Appellees

From the 224th Judicial District Court, Bexar County, Texas

Trial Court No. 2011-CI-07922

Honorable Cathleen M. Stryker, Judge Presiding

O R D E R

Appellant's second motion for extension of time to file brief is hereby GRANTED. Time 

is extended to December 19, 2014.

_________________________________

Catherine Stone, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 9th day of December, 2014.

___________________________________

Keith E. Hottle

Clerk of Court
[Federal Register Volume 63, Number 145 (Wednesday, July 29, 1998)]
[Notices]
[Pages 40528-40529]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20271]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The application also will be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act. Unless otherwise noted, nonbanking 
activities will be conducted throughout the United States.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than August 24, 1998.
    A. Federal Reserve Bank of Kansas City (D. Michael Manies, 
Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 
64198-0001:
    1. Vail Banks, Inc., Vail, Colorado; to merge with Telluride 
Bancorp, Ltd., Montrose, Colorado, and thereby indirectly acquire 
Western Bank of Colorado, Norwood, Colorado, and Bank of Telluride, 
Telluride, Colorado.


[[Page 40529]]


    Board of Governors of the Federal Reserve System, July 24, 1998.
Robert deV. Frierson,
Associate Secretary of the Board.
[FR Doc. 98-20271 Filed 7-28-98; 8:45 am]
BILLING CODE 6210-01-F
No. 11-6047.

#### Jeanne Marie Soja, Petitioner v. California.

565 U.S. 983, 132 S. Ct. 507,

181 L. Ed. 2d 357,

2011 U.S. LEXIS 7812.

October 31, 2011.

Petition for writ of certiorari to the Court of Appeal of California, Sixth Appellate District, denied.
25 June 2014 ********************

NSN: 8920-01-615-1851 (SPC) * MONOGRAPH 3A28 

 *********************

 

Item: Sweet potato walnut cake with white icing

Document: PCR-C-024, Cakes and Brownies, Packaged in a Polymeric Tray, Shelf Stable

Approximate Caloric Value Per Serving: 210 Component Classification: Secondary

Estimated Shelf Life: 36 months at 80°F

Item Characteristics

Appearance:

Cake: Medium golden brown surface, light to medium tan crumb with small pieces of 

walnuts distributed throughout.

Icing: Shiny, white.

Odor: Cake: Slight spice.

Icing: Sweet.

Flavor: Cake: Slight sweet potato, slight spice.

Icing: Sweet.

Texture: Cake: Dense, tender, moist, fine grain with walnut pieces.

Icing: Smooth, easily spreadable.

Possible Deteriorative Changes 

Appearance:

Cake: Excessively moist, sticky surface or excessively dry surface and/or excessively 

dark surface and/or crumb. 

Icing: Darkened, separated, oily.

Odor: Cake: Rancid, oxidized, scorched, musty.

Icing: Oxidized.

Flavor: Cake: Rancid, oxidized, scorched, musty.

Icing: Oxidized.

Texture: Cake: Excessively moist or excessively dry and crumbly.

Icing: Crystallized, weepy.

Unique Examination/Test Procedures

NA

Special Notes

NA
No. 11-6719.

#### Quinn Aaron Klein, Petitioner v. Eric Franklin, Warden.

565 U.S. 1082, 132 S. Ct. 822,

181 L. Ed. 2d 532,

2011 U.S. LEXIS 8815.

December 5, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.

Same case below, 437 Fed. Appx. 681.
No. 11-5597.

#### David Leslie Murtishaw, Petitioner v. California.

565 U.S. 947, 132 S. Ct. 405,

181 L. Ed. 2d 264,

2011 U.S. LEXIS 7398.

October 11, 2011.

Petition for writ of certiorari to the Supreme Court of California denied.

Same case below, 51 Cal. 4th 574, 121 Cal. Rptr. 3d 586, 247 P.3d 941.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule contains summary financial information extracted from
     SEC Form 10-Q and is qualified in its entirety by reference to such
     financial statements
</LEGEND>
<CIK>                         0001067173
<NAME>                        CORPORATE REALTY CONSULTANTS, INC.
<MULTIPLIER>                                      1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         2,416
<SECURITIES>                                       0
<RECEIVABLES>                                    638
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                                   0<F1>
<PP&E>                                        32,730
<DEPRECIATION>                                11,077
<TOTAL-ASSETS>                                29,866
<CURRENT-LIABILITIES>                              0<F1>
<BONDS>                                    21,622
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<COMMON>                                         268
<OTHER-SE>                                     3,267
<TOTAL-LIABILITY-AND-EQUITY>                  29,866
<SALES>                                            0
<TOTAL-REVENUES>                               2,138
<CGS>                                              0
<TOTAL-COSTS>                                  2,173
<OTHER-EXPENSES>                                   0
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                               676
<INCOME-PRETAX>                                 (437)
<INCOME-TAX>                                    (190)
<INCOME-CONTINUING>                             (247)
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                    (247)
<EPS-PRIMARY>                                   (.09)
<EPS-DILUTED>                                   (.09)
<FN>
<F1>CRC does not report using a clasified balance sheet.
</FN>
        


</TABLE>
IIB 

116TH CONGRESS 

1ST SESSION H. R. 3329 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 17, 2019 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at 5186 Benito Street in Montclair, California, 

as the ‘‘Paul Eaton Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pamtmann on DSKBC07HB2PROD with BILLS
2 

HR 3329 RFS

1 SECTION 1. PAUL EATON POST OFFICE BUILDING. 

2 (a) DESIGNATION.—The facility of the United States 

3 Postal Service located at 5186 Benito Street in Montclair, 

4 California, shall be known and designated as the ‘‘Paul 

5 Eaton Post Office Building’’. 

6 (b) REFERENCES.—Any reference in a law, map, reg7 ulation, document, paper, or other record of the United 

8 States to the facility referred to in subsection (a) shall 

9 be deemed to be a reference to the ‘‘Paul Eaton Post Of10 fice Building’’. 

Passed the House of Representatives October 16, 

2019. 

Attest: CHERYL L. JOHNSON, 

Clerk. 


pamtmann on DSKBC07HB2PROD with BILLS
NOTE: This disposition is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

CAP CO., LTD.,

Appellant

v.

MCAFEE, LLC, FKA MCAFEE, INC.,

Appellee

______________________ 

2017-1989, 2017-1990, 2017-1991, 2017-1992

______________________ 

Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. 

IPR2015-01855, IPR2015-01877, IPR2016-00216, 

IPR2016-00222. 

______________________ 

JUDGMENT

______________________ 

BRUCE JOSHUA WECKER, Hausfeld LLP, San Francisco, CA, and ROBERT YORIO, Carr & Ferrell LLP, Menlo 

Park, CA, argued for appellant. Also represented by JOHN 

STEVEN FERRELL, WADE YAMAZAKI. 

 JAMES F. VALENTINE, Perkins Coie, LLP, Palo Alto, 

CA, argued for appellee. Also represented by NANCY 

CHENG; DAN L. BAGATELL, Hanover, NH; KYLE M.

AMBORN, RYAN J. MCBRAYER, Seattle, WA. 
 ______________________ 

THIS CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

 PER CURIAM (LOURIE, O’MALLEY, and CHEN, Circuit 

Judges).

AFFIRMED. See Fed. Cir. R. 36.

 

 ENTERED BY ORDER OF THE COURT 

 

 July 11, 2018 /s/ Peter R. Marksteiner

 Date Peter R. Marksteiner

 Clerk of Court
***************************

 * MONOGRAPH NO: 1A1C

 ***************************

ITEM: Eggs with Turkey Sausage and Potato (ETP) (PRIMARY)

NSN: 8940-01-484-0504 ITEM SPECIFICATION: PCR-E-010 Can

 8940-03-484-0506 PCR-E-011 Poly

CHARACTERISTICS OF ITEM:

APPEARANCE: pale yellow egg, soft curds; sausage and potatoes dispersed 

throughout the product; pale tan/pink sausage pieces with finely ground 

spice specks; pale diced medium sized (1/2 inch) potato

ODOR: spicy sage flavored sausage; mild cooked egg; slight sulfur odor; 

slight canned egg identity

FLAVOR: spicy sage flavored sausage, slightly peppery sausage; mild egg 

with slight sulfur note; low potato identity

TEXTURE: soft moist egg curds; slightly dry tender/ chewy sausage pieces; 

moderately firm intact tender potatoes; low oil identity

ESTIMATED SHELF-LIFE AT: 80 DEGREES F: 36 months

 100 DEGREES F: 6 months

POSSIBLE DETERIORATIVE CHANGES:

Appearance: darkening or discoloration of eggs, turkey sausage, and potato

Odor: off, rancid, scorched odors or loss of odor from turkey sausage; 

sulfur, cooked egg

Flavor: off, rancid, scorched flavors or loss of flavor from turkey sausage; 

sulfur cooked egg

Texture: dry, tough, rubbery, or softening of turkey sausage; rubbery egg; 

softening of potatoes

 

UNIQUE EXAMINATION/TEST PROCEDURES: None
208

Centers for Disease Control and Prevention

National Center for Immunization and Respiratory Diseases

Work Group considerations regarding maternal RSV 

vaccine

Katherine Fleming-Dutra, MD FAAP

Co-lead, Maternal/Pediatric RSV Work 

Group 

ACIP General Meeting

February 23, 2023
209

 Should the Pfizer RSV bivalent prefusion F vaccine be recommended for 

all pregnant people as a single dose given at 24‒36 weeks gestation?

 This recommendation would be considered in the context of the current 

standard of care for prevention of RSV disease in infants at the time of 

ACIP vote. 

Policy question being considered by the work group
210

 Dosing window in the trial was 24 through 36 weeks gestation

 Currently there are no data available on efficacy stratified by gestational age at time 

of administration 

 Majority of infants in phase 3 trial were born ≥37 weeks gestation (94% in RSV 

bivalent preF arm and 95% in placebo arm)

 Most doses in the phase 3 trial were given at ≥28 weeks gestation

– 25% doses given at ≥24 to <28 weeks

– 30% doses given at ≥28 to <32 weeks

– 45% doses given at ≥32 to <37 weeks

– 0.1% doses given at ≥37 weeks

Key considerations regarding RSV bivalent prefusion F 

vaccine: timing of dose within pregnancy

Data provided by Pfizer
211

 All pregnant people in the trial received their first and only dose of RSV 

vaccine

 Currently there are no data available on

–Efficacy of the first lifetime dose during subsequent pregnancies

–Safety of additional doses given in subsequent pregnancies

Key considerations for RSV bivalent prefusion F vaccine: 

number of total lifetime doses 
212

 June 2023

– Summary of GRADE

– Cost effectiveness analysis

– EtR

 October 2023

– ACIP vote (if product is licensed by this time)

Proposed timeline of future ACIP presentations (tentative)
213
Non-employee Director Compensation Policy



 EXHIBIT 10.23 
 RIB-X PHARMACEUTICALS, INC. 
 Non-Employee Director Compensation Policy

 (effective as of [the IPO closing date], 2012) 
 The Board of Directors of Rib-X Pharmaceuticals, Inc. (the “Company”) has approved the following Non-Employee Director Compensation Policy (the “Policy”) which
establishes compensation to be paid to non-employee directors of the Company, effective as of the closing of the Company’s initial public offering of common stock (the “Effective Time”), to provide an inducement to obtain and
retain the services of qualified persons to serve as members of the Company’s Board of Directors. 
 Applicable Persons 

This Policy shall apply to each director of the Company who is not an employee of, or compensated consultant to, the Company or any
Affiliate (each, an “Outside Director”). “Affiliate” shall mean a corporation which is a direct or indirect parent or subsidiary of the Company, as determined pursuant to Section 424 of the Internal Revenue Code of 1986,
as amended. 
 Cash Fees 
 Annual Retainer 
 An annual retainer amount of $50,000 shall be paid to each
of the Outside Directors serving on the Board of Directors. 
 Payment Terms for Annual Retainer 

The total annual retainer shall be paid once per year. Following an Outside Director’s first election or appointment to the Board of
Directors, such Outside Director shall receive his or her cash compensation pro rated beginning on the date he or she was initially appointed or elected. If an Outside Director dies, resigns or is removed during any quarter, he or she shall be
entitled to a cash payment on a pro rated basis through his or her last day of service. 
 Expenses 

Upon presentation of documentation of such expenses reasonably satisfactory to the Company, each Outside Director shall be reimbursed for
his or her reasonable out-of-pocket business expenses incurred in connection with attending meetings of the Board of Directors and Committees thereof or in connection with other business related to the Board of Directors. 

Amendments 
 The
Compensation Committee or the Board of Directors shall review this Policy from time to time to assess whether any amendments in the type and amount of compensation provided herein should be adjusted in order to fulfill the objectives of this Policy.